SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
Viking Therapeutics, Inc.
@VKTX_InsiderForm 4 Filing: ZANTE GREG Sells $710,141.477 of $VKTX
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Viking Therapeutics, Inc.
Ticker: $VKTX
Transaction Value
$710,141.477
Price/Share: $13.43
transaction date
2026-07-29
Shares: 52,884
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ZANTE GREG, holds the title of Chief Financial Officer at Viking Therapeutics, Inc..
On 2026-07-29, the insider transacted 52,884 shares.The shares were transacted at a weighted average price of $13.43 per share, resulting in a total market-relevant value of $710,141.477.
Executive Summary Summary
ZANTE GREG (Chief Financial Officer) sold $710K of $VKTX
Post-Transaction Position: 212,204 shares
SEC Accession No: 0001193125-26-324447 (CIK: 1264949)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.